Login to Your Account



Canaan Closes $600M Fund; Building on Past Successes

By Trista Morrison
Staff Writer

Wednesday, January 11, 2012
Despite a recent wave of contraction in the health care venture capital industry, Canaan Partners raised $600 million in its ninth fund. Granted, the bulk will go to tech investments, but about $100 million is earmarked for drug developers, and a further $100 million will go to medical device, diagnostics and health care IT firms.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription